Xilio Therapeutics, Inc. (XLO) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $119.41M | +123.3% |
| 2024 | $53.48M | +121.9% |
| 2023 | $24.10M | -28.1% |
| 2022 | $33.52M | +2.7% |
| 2021 | $32.63M | -21.6% |
| 2020 | $41.60M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $119.41M | +123.3% |
| 2024 | $53.48M | +121.9% |
| 2023 | $24.10M | -28.1% |
| 2022 | $33.52M | +2.7% |
| 2021 | $32.63M | -21.6% |
| 2020 | $41.60M | — |